[Usefulness of the determination of CEA and Ca 19-9 in the diagnosis and staging of bronchial carcinoma].
The value of CEA and Ca 19-9 assays in the diagnosis and staging of lung cancer is examined. The particular sensitivity of CEA especially in extensive or metastasised tumours is demonstrated. The minimal sensitivity of Ca 19-9 is pointed out but also its absolute specificity in high risk control groups (smokers and BPCO). It is therefore concluded that Ca 19-9 might be used together with CEA in the diagnosis and staging of lung cancer.
Rapellino
M
M
Pecchio
F
F
Baldi
S
S
Obert
R
R
Bevilacqua Rapellino
A
A
Libertucci
D
D
Coni
F
F
Oliaro
A
A
D000951:Antigens, Neoplasm / Q000032:analysis*; D015295:Antigens, Tumor-Associated, Carbohydrate; D002272:Carcinoembryonic Antigen / Q000032:analysis*; D006801:Humans; D008173:Lung Diseases, Obstructive / Q000097:blood; D008175:Lung Neoplasms / Q000097:blood* / Q000473:pathology; D009367:Neoplasm Staging
D000951:Antigens, Neoplasm; D015295:Antigens, Tumor-Associated, Carbohydrate; D002272:Carcinoembryonic Antigen
Utilità della determinazione di CEA e Ca 19-9 nella diagnosi e stadiazione del carcinoma bronchiale.